73 results
Beyond the evolution! Latest image guided therapy for structural heart disease intervention 2.0 era
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session in japanese to learn more about EchoNavigator, an innovative tool for guidance of interventional procedures in structural heart disease, and discover how it may help you achieve a better patient outcome.
Large-scale assessment of a Smartwatch to identify atrial fibrillation
16 Dec 2019
The study aimed to evaluate the capabilities of correctly detecting episodes of Atrial fibrillation/flutter (Afib) through a smartwatch-based irregular pulse notification algorithm of the Apple watch.
Reviewer
New innovative solutions for serious needs: check it out!
28 Aug 2019 – From EuroPCR 2019
Consult this session to discover new innovative solutions for serious needs, such as the Ultraseal device, the V-LAP system, and more!
Prospective concurrent head-to head comparison of three different types of nitinol occluder device for transcatheter closure of secundum ASD
08 Aug 2019
Previous comparisons between AMPLATZER septal occluders and other designs were retrospective, non-randomised, non-concurrent and involved fewer patients... A prospective concurrent head-to-head comparison of AMPLATZER (ASO), Cera (CSO) and Figulla (FSO) septal occluders was planned to study the patient outcomes.
Authors :
A novel atrial flow regulator in heart failure patients
Martin W. Bergmann presents the 3-month results of the PRELIEVE Trial, a pilot study to assess the safety and efficacy of a novel atrial flow regulator that aims to reduce elevated left atrial pressure in patients with heart failure. Can the device improve symptoms of dyspnoea...
Percutaneous edge-to-edge repair in patients with heart failure and secondary mitral regurgitation
Anna Sonia Petronio, Francesco Maisano and Bernard Prendergast discuss the background to the PCR statement on percutaneous edge-to-edge repair in patients with heart failure and secondary mitral regurgitation in light of opposing results from the COAPT and MITRA-FR randomised controlled trials. They explain the reasons for the...
Transcatheter left atrial decompression for chronic heart failure: evidence, indications and device options
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the role of left atrial decompression in the multidisciplinary management of chronic heart failure, the device selection, their specifics and how to use them, and more!
Innovative First-in-Man trials and early phase studies
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about innovative First-in-Man trials and early phase studies regarding hypertension, chronic heart failure and renal denervation, such as: TROPHY1, Cryo-RDN, AFR-Prelieve, and more!
Assist devices for chronic heart failure
21 May 2019 – From EuroPCR 2019
Consult this session to learn more about assist devices for chronic heart failure, and discover compelling cases such as: atrial septostomy for the management of heart failure, closure of subaortic VSD in a patient with three biological prosthesis, and more!
Devices in chronic heart failure: an update for the interventionalist
21 May 2019 – From EuroPCR 2019
Consult this session on device-based monitoring, neuromodulation and left ventricular aneurysmectomy, in order to better understand the contribution of devices to the management of chronic heart failure and the concepts of optimal patient and device selection.
